1. Videbaek J, Christensen NJ, Sterndorff B: Serial determination of plasma catecholamines in myocardial infarction. Circulation46: 846–855, 1972.
2.
2. Allison SP, Chamberlain MJ, Hinton P: Intravenous glucose tolerance, insulin, glucose, and free fatty acid levels after myocardial infarction. Br Med J4:776–778, 1969.
3.
3. Taylor SH, Majid PA, Ghosh P, et al: Insulin secretion following myocardial infarction. Lancet2:1373–1378, 1969.
4.
4. Vetter NJ, Adams W, Strange RC, et al: Initial metabolic and hormonal response to acute myocardial infarction. Lancet1:284–289, 1974.
5.
5. Oliver MF, Kurien VA, Greenwood TW: Relation between serum-free-fatty-acids and arrhythmias and death after acute myocardial infarction. Lancet1:710–715, 1968.
6.
6. Christensen NJ, Videbaek J: Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction. J Clin Invest54:278–286, 1974.
7.
7. Kjekshus JK, Mjøs OD: Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart. J Clin Invest51:1767–1776, 1972.
8.
8. Opie LH: Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Am J Cardiol36:938–953, 1975.
9.
9. Bailey RR, Abernethy MH, Beaven DW: Adrenocortical response to the stress of an acute myocardial infarction. Lancet1:970–973, 1967.
10.
10. Arora RB: Role of aldosterone in myocardial infarction. Ann NY Acad Sci118:537–554, 1965.
11.
11. Hutcheson D, Faloona GR, Leshin SJ, et al: Serum glucagon and insulin levels and their relationship to blood glucose values in patients with acute myocardial infarction. Circulation7&8 (Suppl 4):179, 1973.
12.
12. Strange RC, Vetter N, Rowe MJ, et al: Plasma cyclic AMP and total catecholamines during acute myocardial infarction in man. Eur J Clin Invest4:115–119, 1974.
13.
13. Johansson BG, Kindmark C-O, Trell EY, et al: Sequential changes of plasma proteins after myocardial infarction. Scand J Clin Lab Invest29 (Suppl 124):117–126, 1972.
14.
14. Avogaro P, Bittolo Bon G, Cazzolato G, et al: Variations in apolipoproteins B and A1 during the course of myocardial infarction. Eur J Clin Invest8:121–129, 1978.
15.
15. Altschule MD, Rosenfeld FM: Increased catabolism following acute myocardial infarction. Arch Int Med80:74–80, 1947.
16.
16. Tietzè VK, Schulz FH: Über den Stickstoffhaushalt beim Myokardieinfarkt. Schweiz Med Wochenschr83:34–36, 1953.
17.
17. Warren SE, Alpert JS, Francis GS: Diet in the coronary care unit. Am Heart J95:130–131, 1978.
18.
18. Kleinberger VG, Kotzaurek R, Pall H, et al: Partielle parenterale Ernährung (PPE) beim akuten Herzinfarkt. Wien Klin Wochenschr87:634–639, 1975.
19.
19. Noelle H, Geisse S: Totale parenterale Ernährung und Stickstoff-bilanz beim Myokardiinfarkt. Infusionstherapie5:181–183, 1978.
20.
20. Mueller HS, Ayres SM: Metabolic responses of the heart in acute myocardial infarction in man. Am J Cardiol42:363–371, 1978.
21.
21. Melsom M, Andreassen P, Melsom H, et al: Diazepam in acute myocardial infarction,. Br Heart J38:804–810, 1976.
22.
22. Christiansen I: Beta-receptorblokerende midler og akut myokardieinfarkt. IN Symposium om nye perspektiver i behandlingen med beta-receptorblokerende midler, Boye E, Aerenlund Jensen H (eds) Copenhagen, ICI Pharma, 1978, pp 36–44
23.
23. Oliver MF, Rowe MJ, Luxton MR, et al: Effect of reducing circulating free fatty acids on ventricular arrhythmias during myocardial infarction and on ST-segment depression during exercise-induced ischemia. Circulation53 (Suppl I):210–213, 1976.
24.
24. Rogers WJ, Segall PH, McDaniel HG, et al: Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction. Am J Cardiol43:801–809, 1979.
25.
25. Moore FD, Brennan MF: Surgical injury: body composition, protein metabolism, and neuroendocrinology. IN Manual of Surgical Nutrition, Ballinger WF, Collins JA, Drucker WR, Dudrick SJ, Zeppa R (eds) Philadelphia, London, Toronto, W. B. Saunders Co., 1975, pp 169–222.
